Peroxisome Membrane Protein PEX16 Inhibits Melanogenesis by Inhibiting the Wnt/β-Catenin Signalling Pathway

Area of Science:

• Dermatology
• Cell Biology
• Molecular Biology

Background:

• Melanogenesis, the process of melanin production, is crucial for skin pigmentation and is implicated in various skin disorders.
• Peroxisomes are vital organelles involved in cellular metabolism, but their role in melanogenesis is not fully understood.

Purpose of the Study:

• To investigate the relationship between peroxisomes, specifically peroxisomal biogenesis factor 16 (PEX16), and melanin synthesis.
• To elucidate the molecular mechanisms by which PEX16 influences melanogenesis and its potential as a therapeutic target for pigmentation disorders.

Main Methods:

• Analysis of omics data and clinical skin samples.
• Overexpression of PEX16 in MNT1 cell lines and primary melanocytes.
• Quantitative analysis of melanin content and gene expression (MITF, TYR, TYRP1, DCT).
• Detection of PEX16 expression in human skin tissues and assessment after UVB irradiation.
• Investigation of the Wnt/β-catenin signaling pathway.

Main Results:

• PEX16 expression was negatively associated with melanogenesis.
• Overexpression of PEX16 increased peroxisome production and inhibited key melanogenesis genes (MITF, TYR, TYRP1, DCT).
• PEX16 overexpression in melanocytes significantly reduced melanin content.
• PEX16 expression was higher in less pigmented skin areas and decreased after UVB exposure.
• PEX16 was found to suppress the Wnt/β-catenin signaling pathway.

Conclusions:

• PEX16 inhibits melanogenesis by suppressing the Wnt/β-catenin signaling pathway.
• PEX16 plays a significant role in regulating skin pigmentation.
• PEX16 represents a potential therapeutic target for managing skin pigmentation disorders.